Latest from Christopher Rowland

Maryland biotech has a rich story but faces turbulence over looming competition.

  • Apr 19, 2019

Despite the president’s rhetoric on costs, the Commerce Department has proposed a curb on federal licensing power.

  • Apr 18, 2019

Trump administration seeks to avoid political land mine created by ban on drug rebates.

  • Apr 9, 2019

Critics say the CDC is “twiddling their thumbs” and failing to leverage patent for public health.

  • Mar 26, 2019

Chuck Grassley opened the hearing saying that Americans are “sick and tired of the blame game.”

  • Feb 26, 2019

Pharmaceutical CEOs are expected to deflect blame at Senate hearing

  • Feb 25, 2019

Companies are using wearables to help employees get fit and save on health care, all while getting access to troves of individual data.

  • Feb 16, 2019

“It was the fox guarding the henhouse,” said the lead investigator in a case against generic drug manufacturers.

  • Feb 1, 2019

The draft rule would bar the widespread practice of rebates for middlemen, spurring changes in how drugs are priced.

  • Jan 31, 2019
Load More